Flemming Ørnskov

Flemming Ørnskov
Nationality	Danish
Alma mater	University of Copenhagen INSEAD Harvard University
Occupation	CEO, Shire plc
Salary	US$4,137,000 (total compensation, 2014)

Flemming Ørnskov is a Danish businessman who has been the chief executive officer (CEO) of Shire plc, a FTSE 100 speciality biopharmaceutical company since 30 April 2013, succeeding Angus Russell. He previously worked for Bayer.

Ornskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.

...
Wikipedia